From: Influenza NG-34 T cell conserved epitope adjuvanted with CAF01 as a possible influenza vaccine candidate
Group
n
Antigen
Adjuvant
Inoculation route
A
3
–
B
4
NG-34
s.c.
C
5
Alhydrogel 2.0%
D
AddaVax™
E
CAF01
F
Diluvac Forte®